Conference Coverage

October 19, 2017

Specialty drug pipeline predictions: Seven key areas to watch

The specialty drugs market will see more approvals in 2017 than 2016. Top areas to watch include cancer, multiple sclerosis, and HIV.

Highly specific indications dominate cancer drug pipeline

Recent and pending drug approvals emphasize the growing importance of niche agents for very specific cancer patient populations.

Monetary benefits from value-based diabetes plans take time

Value-based insurance designs for diabetes care improve outcomes, but do they lead to cost savings?

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.

>>>>>>>>>>>